Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02087241
Title Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca

lung non-small cell carcinoma



Carboplatin + Pemetrexed Disodium

Age Groups: adult
Covered Countries USA

No variant requirements are available.